BOSTON SCIENTIFIC CORPORATION (BSX) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 539.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $539.00M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $1.45B | (m) | (m) |
| 2025-12-31 | (m) | (m) | $1.97B | (m) | (m) |
| 2025-09-30 | (m) | (m) | $1.27B | (m) | (m) |
| 2025-06-30 | (m) | (m) | $534.00M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $725.00M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $414.00M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $2.50B | (m) | (m) |
| 2024-06-30 | (m) | (m) | $2.91B | (m) | (m) |
| 2024-03-31 | (m) | (m) | $2.33B | (m) | (m) |
| 2023-12-31 | (m) | (m) | $865.00M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $952.00M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $426.00M | (m) | (m) |
| 2023-03-31 | (m) | (m) | $570.00M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $928.00M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $338.00M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $276.00M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $325.00M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $1.93B | (m) | (m) |
| 2021-09-30 | (m) | (m) | $1.95B | (m) | (m) |
| 2021-06-30 | (m) | (m) | $2.67B | (m) | (m) |
| 2021-03-31 | (m) | (m) | $2.02B | (m) | (m) |
| 2020-12-31 | (m) | (m) | $1.73B | (m) | (m) |
| 2020-09-30 | (m) | (m) | $2.02B | (m) | (m) |
| 2020-06-30 | (m) | (m) | $1.72B | (m) | (m) |
| 2020-03-31 | (m) | (m) | $370.00M | (m) | (m) |
| 2019-12-31 | (m) | (m) | $217.00M | (m) | (m) |
| 2019-09-30 | (m) | (m) | $277.00M | (m) | (m) |
| 2019-06-30 | (m) | (m) | $123.00M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $139.00M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $146.00M | (m) | (m) |
| 2018-09-30 | (m) | (m) | $168.00M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $208.00M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $287.00M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $188.00M | (m) | (m) |
| 2017-09-30 | (m) | (m) | $210.00M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $195.00M | (m) | (m) |
| 2017-03-31 | (m) | (m) | $156.00M | (m) | (m) |
| 2016-12-31 | (m) | (m) | $196.00M | (m) | (m) |
| 2016-09-30 | (m) | (m) | $237.00M | (m) | (m) |
| 2016-06-30 | (m) | (m) | $438.00M | (m) | (m) |
| 2016-03-31 | (m) | (m) | $338.00M | (m) | (m) |
| 2015-12-31 | (m) | (m) | $319.00M | (m) | (m) |
| 2015-09-30 | (m) | (m) | $350.00M | (m) | (m) |
| 2015-06-30 | (m) | (m) | $903.00M | (m) | (m) |
| 2015-03-31 | (m) | (m) | $242.00M | (m) | (m) |
| 2014-12-31 | (m) | (m) | $587.00M | (m) | (m) |
| 2014-09-30 | (m) | (m) | $246.00M | (m) | (m) |
| 2014-06-30 | (m) | (m) | $357.00M | (m) | (m) |
| 2014-03-31 | (m) | (m) | $191.00M | (m) | (m) |
| 2013-12-31 | (m) | (m) | $217.00M | (m) | (m) |
| 2013-09-30 | (m) | (m) | $571.00M | (m) | (m) |
| 2013-06-30 | (m) | (m) | $530.00M | (m) | (m) |
| 2013-03-31 | (m) | (m) | $268.00M | (m) | (m) |
| 2012-12-31 | (m) | (m) | $207.00M | (m) | (m) |
| 2012-09-30 | (m) | (m) | $352.00M | (m) | (m) |
| 2012-06-30 | (m) | (m) | $371.00M | (m) | (m) |
| 2012-03-31 | (m) | (m) | $284.00M | (m) | (m) |
| 2011-12-31 | (m) | (m) | $267.00M | (m) | (m) |
| 2011-09-30 | (m) | (m) | $276.00M | (m) | (m) |
| 2011-06-30 | (m) | (m) | $154.00M | (m) | (m) |
| 2011-03-31 | (m) | (m) | $595.00M | (m) | (m) |
| 2010-12-31 | (m) | (m) | $213.00M | (m) | (m) |
| 2010-09-30 | (m) | (m) | $624.00M | (m) | (m) |
| 2010-06-30 | (m) | (m) | $811.00M | (m) | (m) |
| 2010-03-31 | (m) | (m) | $519.00M | (m) | (m) |
| 2009-12-31 | (m) | (m) | $864.00M | (m) | (m) |
| 2009-09-30 | (m) | (m) | $1.38B | (m) | (m) |
| 2009-06-30 | (m) | (m) | $1.19B | (m) | (m) |
| 2009-03-31 | (m) | (m) | $897.00M | (m) | (m) |
| 2008-12-31 | (m) | (m) | $1.64B | (m) | (m) |
| 2008-09-30 | (m) | (m) | $1.73B | (m) | (m) |
| 2008-06-30 | (m) | (m) | $1.62B | (m) | (m) |
| 2007-12-31 | (m) | (m) | $1.45B | (m) | (m) |
| 2006-12-31 | (m) | (m) | $1.67B | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |